Mouse Factor IX Genetically Deficient Plasma, Sodium Citrate
Cat# MBS136092-0,1mL
Size : 0.1mL
Brand : MyBiosource
F9 Plasma – Factor IX
For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS136092This plasma is an ideal negative control for ELISA based assays and other experiments involving Factor IX. Collected from homozygous Factor IX knockout mice, anticoagulated with sodium citrate and flash frozen. Collected from female mice. Male mouse plasma is… More details
Product Overview
Online Datasheet in PDFProduct Name
Factor IX (F9), Plasma
Full Product Name
Mouse Factor IX Genetically Deficient Plasma, Sodium Citrate
Product Gene Name
F9 plasma
Host
Mouse
Form/Format
Frozen Liquid
Purity/Purification
Plasma
Preparation and Storage
Store at -70 degree C.
Other Notes
Small volumes of F9 plasma vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Searchable Terms for F9 purchase
MBS136092 is a plasma targeting F9. Also known as Mouse Factor IX Genetically Deficient Plasma, Sodium Citrate. Host: Mouse.
Additional Details
NCBI/Uniprot data below describe general gene information for F9. It may not necessarily be applicable to this product.
UniProt Primary Accession #
UniProt Secondary Accession #
UniProt Related Accession #
GenBank Nucleotide #
NCBI Official Full Name
coagulation factor IX isoform 2
NCBI Official Synonym Full Names
coagulation factor IX
NCBI Official Symbol
F9
NCBI Official Synonym Symbols
Cf9; Cf-9; AW111646
UniProt Protein Name
Coagulation factor IX
UniProt Synonym Protein Names
Christmas factor
Protein Family
Coagulation factor
UniProt Gene Name
F9
UniProt Synonym Gene Names
Cf9
NCBI Protein Information
coagulation factor IX
NCBI Summary for F9
This gene encodes a vitamin K-dependent serine protease that plays a critical role in the intrinsic pathway of blood coagulation. The encoded protein is an inactive zymogen that is activated by coagulation factor XIa to generate factor IXa, a heterodimer containing heavy and light chains. In association with factor VIII, membrane phospholipids and calcium ions, factor IXa cleaves the inactive zymogen factor X to generate active factor Xa. Genetic deletion of this gene in mice results in a severe bleeding phenotype. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Apr 2015]
Show more UniProt Comments for F9
Factor IX is a vitamin K-dependent plasma protein that participates in the intrinsic pathway of blood coagulation by converting factor X to its active form in the presence of Ca2+ ions, phospholipids, and factor VIIIa.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
Product Note
Select online data sheet information is drawn from bioinformatics databases, occasionally resulting in ambiguous or non-relevant product information. It is the responsibility of the customer to review, verify, and evaluate the information to make sure it matches their requirements before purchasing the kit. Our ELISA Kit assays are dynamic research tools and sometimes they may be updated and improved. If the format of this assay is important to you then please request the current manual or contact our technical support team with a presales inquiry before placing an order. We will confirm the current details of the assay. We cannot guarantee the sample manual posted online is the most current manual, it is intended to serve as an example only. Please refer to the instructions For Use provided with the assay kit for precise details.
Product PubMed Publications
Products associated with F9 plasma
| Reference Product | PubMed Publications |
|---|---|
| F11 plasma | >28 publications with F9 and F11 |
| F12 plasma | >24 publications with F9 and F12 |
| Vwf plasma | >8 publications with F9 and Vwf |
| Serpinc1 plasma | >6 publications with F9 and Serpinc1 |
| Ggcx plasma | >1 publications with F9 and Ggcx |
Pathways associated with F9 plasma
| Products by Pathway | Pathway Diagram |
|---|---|
| Blood Clotting Cascade Pathway antibodies | Blood Clotting Cascade Pathway Diagram |
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Complement And Coagulation Cascades Pathway antibodies | Complement And Coagulation Cascades Pathway Diagram |
| Extrinsic Pathway Of Fibrin Clot Formation antibodies | Extrinsic Pathway Of Fibrin Clot Formation Diagram |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway antibodies | Formation Of Fibrin Clot (Clotting Cascade) Pathway Diagram |
| Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation Pathway antibodies | Gamma Carboxylation, Hypusine Formation And Arylsulfatase Activation Pathway Diagram |
| Gamma-carboxylation Of Protein Precursors Pathway antibodies | Gamma-carboxylation Of Protein Precursors Pathway Diagram |
| Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway antibodies | Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway Diagram |
| Hemostasis Pathway antibodies | Hemostasis Pathway Diagram |
Diseases associated with F9 plasma
| Disease Name | Pubmed Publications |
|---|---|
| Carcinoma Antibodies | >881 publications with F9 and Carcinoma |
| Hemophilia B Antibodies | >109 publications with F9 and Hemophilia B |
| Cell Transformation, Neoplastic Antibodies | >75 publications with F9 and Cell Transformation, Neoplastic |
| Neurobehavioral Manifestations Antibodies | >43 publications with F9 and Neurobehavioral Manifestations |
| Immune System Diseases Antibodies | >39 publications with F9 and Immune System Diseases |
| Mental Disorders Antibodies | >25 publications with F9 and Mental Disorders |
| Hemophilia A Antibodies | >24 publications with F9 and Hemophilia A |
| Liver Neoplasms Antibodies | >23 publications with F9 and Liver Neoplasms |
| Adenocarcinoma Antibodies | >23 publications with F9 and Adenocarcinoma |
| Cardiovascular Diseases Antibodies | >22 publications with F9 and Cardiovascular Diseases |
Organs/Tissues associated with F9 plasma
| Organ/Tissue Name | Pubmed Publications |
|---|---|
| Embryonic Tissue Antibodies | >158 publications with F9 and Embryonic Tissue |
| Liver Antibodies | >107 publications with F9 and Liver |
| Muscle Antibodies | >51 publications with F9 and Muscle |